COVID-19 Claims Reimbursement for Testing and Treating Uninsured Patients

InsightsClient Alert

A portion of the $100 billion Provider Relief Fund will be used to reimburse healthcare providers for COVID-related treatment of the uninsured.  Every health care provider who has provided testing or treatment for uninsured COVID-19 patients on or after February 4, 2020, can electronically request claims reimbursement through the program and will be reimbursed at Medicare rates, subject to available funding.  All claims submitted must be complete and final and will be subject to the same timely filing requirements required by Medicare.

Steps will involve enrolling as a provider participant, checking patient eligibility and benefits, submitting patient information, submitting claims, and receiving payment via direct deposit.  To participate, providers must attest to the following:

  • You have checked for health care coverage eligibility and confirmed that the patient is uninsured. You have verified that the patient does not have individual, employer-sponsored, Medicare or Medicaid coverage, and no other payer will reimburse you for COVID-19 testing and/or care for that patient.
  • You will accept defined program reimbursement as payment in full.
  • You agree not to balance bill the patient.
  • You agree to program terms and conditions and may be subject to post-reimbursement audit review.

Providers can register for the program on April 27, begin submitting claims on May 6, and start receiving reimbursement in mid-May.  On Demand training starts April 29.

For more information, visit https://www.hrsa.gov/coviduninsuredclaim.

At Draffin & Tucker, LLP we are committed to providing our clients with the latest information related to COVID-19.  Please do not hesitate to contact us with any questions or concerns.  Visit our COVID-19 webpage for more information and updates.

Access all Client Alerts by clicking here.